uplisting Archives - Sichenzia Ross Ference Carmel LLP

Sichenzia Ross Ference LLP Congratulates Relmada Therapeutics, Inc., on NASDAQ Uplisting

By Sichenzia Ross Ference LLP | October 10, 2019

New York, NY – October 10, 2019 – Sichenzia Ross Ference LLP announced today that the firm represented Relmada Therapeutics, Inc. (NASDAQ: RLMD), in the Company’s up-listing to the NASDAQ Capital Market. The Sichenzia Ross Ference LLP team was led by Gregory Sichenzia and partner Barrett DiPaolo. The up-listing is effective for trading on October…

Carmel, Milazzo & Feil LLP Represents Network 1 Financial Securities, Inc. as Selling Agent and Alexander Capital L.P. as Selected Dealer in a $6.9 Million Public Offering and Uplisting to NASDAQ

By Sichenzia Ross Ference LLP | July 29, 2016

Network 1 Financial Securities, Inc.

$6,900,000

Public Offering

July 2016

Sichenzia Ross Friedman Ference Congratulates DelMar Pharmaceuticals, Inc. on NASDAQ Uplisting

By Sichenzia Ross Ference LLP | July 11, 2016

New York, NY – July 11, 2016 – Sichenzia Ross Friedman Ference LLP announced today that the Firm has represented DelMar Pharmaceuticals, Inc. (NASDAQ: DMPI), in the Company’s uplisting to the NASDAQ Capital Market. The Sichenzia Ross Friedman Ference LLP team was led by partners Gregory Sichenzia and David Manno. not assigned nasdaq | pharmaceutical | srff | uplisting